Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04906200 · ClinicalTrials.gov registry record · NA

Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors

A NA study of Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8, sponsored by Ohio State University Comprehensive Cancer Center.

Active
Registry status
NA
Development phase
400
Enrollment target
3
Study locations

NCT04906200 is a NA study of Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8 that is active but no longer recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 400 participants, above the 300-participant average among 84 other Anatomic Stage III Breast Cancer AJCC v8 trials with a reported enrollment target (33% higher). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04906200, a NA study of Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8, is active but no longer recruiting, sponsored by Ohio State University Comprehensive Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
3
Study locations

Study Summary

This clinical trial compares a web-based patient-reported symptom monitoring and self management portal, the Young, Empowered \& Strong (YES), to standard therapy in managing symptoms in adolescent and young adult breast cancer survivors. YES is a web-based portal (website) to help monitor issues or symptoms women with breast cancer may experience. The YES portal may improve the quality of life of young breast cancer survivors. The YES portal may help manage symptoms and provide useful information/resources.

Interventions

  • OTHER Survey Administration
  • OTHER Best Practice
  • OTHER Internet-Based Intervention

Study Locations (3)

Massachusetts

  • Dana Farber Cancer Institute - Boston

New York

  • Columbia University Medical Center - New York

Ohio

  • Ohio State University Comprehensive Cancer Center - Columbus

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2021-06-28
Est. Completion 2026-12-31
Phase NA

What the Registry Record Tells You About NCT04906200

The ClinicalTrials.gov registry entry for NCT04906200 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 300-participant average among 84 other Anatomic Stage III Breast Cancer AJCC v8 trials with a reported enrollment target (33% higher). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Anatomic Stage III Breast Cancer AJCC v8 appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.

NCT04906200 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, New York, Ohio.

Frequently Asked Questions

What is clinical trial NCT04906200 about?

NCT04906200 is a clinical study titled "Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors". This clinical trial compares a web-based patient-reported symptom monitoring and self management portal, the Young, Empowered \& Strong (YES), to standard therapy in managing symptoms in adolescent and young adult breast cancer survivors. YES is a web-based portal (website) to help monitor issues or...

What is the current status of trial NCT04906200?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2021-06-28. Estimated completion is 2026-12-31.

What conditions does trial NCT04906200 study?

This clinical trial studies the following conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8.

What interventions are being tested in trial NCT04906200?

The interventions under investigation include: Survey Administration (OTHER), Best Practice (OTHER), Internet-Based Intervention (OTHER).

Who is sponsoring clinical trial NCT04906200?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04906200 being conducted?

This trial has 3 study locations across Massachusetts, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anatomic Stage III Breast Cancer AJCC v8

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.